IP Library › Granted Patent US 12,478,500
Granted Patent B2
US 12,478,500 · App. 18/307,954 · Granted Nov 25, 2025

Maxillary devices, controller station, and methods of treating and/or diagnosing medical disorders

Inventor: Raghavendra Vitthalrao Ghuge (Tyler, TX)
A61F5/566A61M16/0003A61M16/026A61F2005/563A61M2205/3324A61M2205/3375A61M2205/50A61M2205/8206A61M2205/8237A61M2210/0625
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,500
App. No.
18/307,954
Granted
Nov 25, 2025
Kind
B2
Abstract

Maxillary devices and mandibular devices each have a first housing connectable to a tooth of a user or connectable or integral with a teeth covering, wherein the housing encloses an on-board circuit board and a power source. The first housing of the maxillary devices has a tooth connecting portion, a palate housing portion and/or a buccal housing portion. The first housing of the mandibular devices has a tooth connecting portion and a sublingual portion. Each of the palate housing portion and the buccal housing portion enclose a stimulator having an electrode electrically connected to the on-board circuit board and the power source, and can enclose a sensor and/or a medicament dispenser. Methods of treatment using the same are disclosed also.

Claims (32)

1 . A method of treatment comprising:

providing to a user a maxillary device having a first housing connectable to a tooth of a user or connectable or integral with a teeth covering, wherein the housing encloses an on-board circuit board and a power source and comprises a tooth connecting portion, a sensor in operative communication with the on-board circuit board, and a palate housing portion extending from the tooth connecting portion, wherein the palate housing portion encloses therein a stimulator having an electrode electrically connected to the on-board circuit board and the power source, and the palate housing is contoured to position the stimulator against the soft palate and uvula of a user's mouth, and is configured for the stimulator to stiffen the soft palate and uvula;

activating the maxillary device; and

positioning the maxillary device in the user's oral cavity;

wherein activating the maxillary device comprises, via the sensor, acquiring physiological data from the oral cavity and activating the stimulator as needed in response thereto.

2 . The method of treatment as claimed in claim 1 , wherein the teeth covering has a left molar portion and/or a right molar portion, wherein the tooth connecting portion of the housing is connected to or integral with the teeth covering.

3 . The method of treatment as claimed in claim 1 , wherein the treatment treats snoring, a speech pathology, or a swallowing pathology.

4 . The method of treatment as claimed in claim 1 , wherein the treatment treats post-stroke recovery, reconstructive surgery recovery of the maxilla-facial region, short frenulum syndrome, or micrognathia syndrome.

5 . The method of treatment as claimed in claim 1 , wherein the power source is a rechargeable battery and the first housing has a charging member in an exterior surface thereof that is in electrical communication with the rechargeable battery.

6 . The method of treatment as claimed in claim 1 , wherein the on-board circuit board includes a receiver, a transmitter, and a microprocessor having instructions to activate the stimulator.

7 . The method of treatment as claimed in claim 1 , wherein the sensor is selected from the group consisting of a pulse oxygen sensor, a vibration and airflow sensor, a pH sensor, a doppler ultrasound sensor, an M-Mode ultrasound sensor, a 2D ultrasound sensor, 3D ultrasound sensor, a pressure plate sensor for measuring bruxism, a pulse transit time sensor, non-invasive ventilation systolic/diastolic blood pressure sensor, a carotid doppler (trans-oral) sensor, a cardiac trans-oral echocardiography sensor, and combinations thereof.

8 . The method of treatment as claimed in claim 1 , wherein the maxillary device further comprises a medicament dispenser in electrical communication with the on-board circuit board; and further comprising activating the medicament dispenser to dispense a medicament to a user's oral cavity as needed in response to the physiological data acquired by the sensor.

9 . The method of treatment of claim 8 , wherein the medicament dispenser includes a reservoir housing the medicament.

10 . The method of treatment of claim 9 , wherein the medicament is a pellet, tablet, powder, or liquid.

11 . The method of treatment of claim 8 , wherein the medicament dispenser is housed in the palate portion and has a dispenser head open or openable for communication with the oral cavity.

12 . The method of treatment of claim 1 , wherein the maxillary device further comprises a photograph or videography array oriented to map the oral cavity or an airway structure of the user and/or record sounds of the user.

13 . A method of treatment comprising:

providing to a user a maxillary device having a first housing connectable to a tooth of a user or connectable or integral with a teeth covering and a photograph or videography array oriented to map an airway structure of the user and/or record sounds of the user, wherein the housing encloses an on-board circuit board and a power source and comprises a tooth connecting portion, a sensor in operative communication with the on-board circuit board, and a palate housing portion extending from the tooth connecting portion, wherein the palate housing portion encloses therein a stimulator having an electrode electrically connected to the on-board circuit board and the power source, and the palate housing is contoured to position the stimulator against the soft palate and uvula of a user's mouth, and is configured for the stimulator to stiffen the soft palate and uvula;

activating the maxillary device; and

positioning the maxillary device in the user's oral cavity;

wherein activating the maxillary device comprises, via the sensor, acquiring physiological data from the oral cavity and activating the stimulator as needed in response thereto.

14 . The method of treatment as claimed in claim 13 , wherein the on-board circuit board includes a receiver, a transmitter, and a microprocessor having instructions to activate the stimulator.

15 . The method of treatment as claimed in claim 13 , wherein the sensor is selected from the group consisting of a pulse oxygen sensor, a vibration and airflow sensor, a pH sensor, a doppler ultrasound sensor, an M-Mode ultrasound sensor, a 2D ultrasound sensor, 3D ultrasound sensor, a pressure plate sensor for measuring bruxism, a pulse transit time sensor, non-invasive ventilation systolic/diastolic blood pressure sensor, a carotid doppler (trans-oral) sensor, a cardiac trans-oral echocardiography sensor, and combinations thereof.

16 . The method of treatment as claimed in claim 13 , wherein the maxillary device further comprises a medicament dispenser in electrical communication with the on-board circuit board; and further comprising activating the medicament dispenser to dispense a medicament to a user's oral cavity as needed in response to the physiological data acquired by the sensor.

17 . A method of treatment comprising:

providing to a user a maxillary device having a first housing connectable to a tooth of a user or connectable or integral with a teeth covering and a videography array oriented to record sounds of the user, wherein the housing encloses an on-board circuit board and a power source and comprises a tooth connecting portion, a sensor in operative communication with the on-board circuit board, and a palate housing portion extending from the tooth connecting portion, wherein the palate housing portion encloses therein a stimulator having an electrode electrically connected to the on-board circuit board and the power source, and the palate housing is contoured to position the stimulator against the soft palate and uvula of a user's mouth, and is configured for the stimulator to stiffen the soft palate and uvula;

activating the maxillary device; and

positioning the maxillary device in the user's oral cavity;

wherein activating the maxillary device comprises, via the sensor, acquiring physiological data from the oral cavity and activating the stimulator as needed in response thereto.

18 . The method of treatment as claimed in claim 17 , wherein the on-board circuit board includes a receiver, a transmitter, and a microprocessor having instructions to activate the stimulator.

19 . The method of treatment as claimed in claim 17 , wherein the sensor is selected from the group consisting of a pulse oxygen sensor, a vibration and airflow sensor, a pH sensor, a doppler ultrasound sensor, an M-Mode ultrasound sensor, a 2D ultrasound sensor, 3D ultrasound sensor, a pressure plate sensor for measuring bruxism, a pulse transit time sensor, non-invasive ventilation systolic/diastolic blood pressure sensor, a carotid doppler (trans-oral) sensor, a cardiac trans-oral echocardiography sensor, and combinations thereof.

20 . The method of treatment as claimed in claim 17 , wherein the maxillary device further comprises a medicament dispenser in electrical communication with the on-board circuit board; and further comprising activating the medicament dispenser to dispense a medicament to a user's oral cavity as needed in response to the physiological data acquired by the sensor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2025
From: GHUGE, RAGHAVENDRA VITTHALRAO
To: SLEEP SOLUTIONS OF TEXAS, LLC
Reel/Frame 072731/0240 →
Continuity (4)
Division 16822993 · Mar 18, 2020
Continuation In Part 16784758 · Feb 7, 2020
Provisional Application 62936032 · Nov 15, 2019
Related Publication 20240074893A1 · Mar 7, 2024
References Cited (33)
US 5826579A · Remmers et al. · 1998 [cited by applicant]
US 6536439B1 · Palmisano · 2003 [cited by applicant]
US 6604527B1 · Palmisano · 2003 [cited by applicant]
US 7942824B1 · Kayyali et al. · 2011 [cited by applicant]
US 8355769B2 · Levendowski et al. · 2013 [cited by applicant]
US 9101531B1 · Song · 2015 [cited by applicant]
US 9283150B2 · Bujalski et al. · 2016 [cited by applicant]
US 9579264B1 · Litton · 2017 [cited by applicant]
US 9636279B2 · Song et al. · 2017 [cited by applicant]
US 10185812B2 · Kamen et al. · 2019 [cited by applicant]
US 10265013B2 · Lim · 2019 [cited by applicant]
US 10299992B2 · Mullen · 2019 [cited by applicant]
US 10468132B2 · Kamen et al. · 2019 [cited by applicant]
US 20100076595A1 · Nguyen · 2010 [cited by applicant]
US 20110168187A1 · Nelissen · 2011 [cited by applicant]
US 20120240941A1 · Rosenman et al. · 2012 [cited by applicant]
US 20140134561A1 · Smith et al. · 2014 [cited by applicant]
US 20140135868A1 · Bashyam · 2014 [cited by examiner]
US 20150182374A1 · Stenberg et al. · 2015 [cited by applicant]
US 20160250054A1 · Al-Tawil · 2016 [cited by examiner]
US 20160324681A1 · Flanagan · 2016 [cited by applicant]
US 20170128721A1 · Martin et al. · 2017 [cited by applicant]
US 20170290699A1 · Radmand · 2017 [cited by examiner]
US 20180296441A1 · Roham et al. · 2018 [cited by applicant]
US 20180360646A1 · Bedford · 2018 [cited by applicant]
US 20180368766A1 · Keels · 2018 [cited by applicant]
US 20190091061A1 · Radmand · 2019 [cited by applicant]
US 20190110746A1 · Dau et al. · 2019 [cited by applicant]
US 20190350749A1 · Winter et al. · 2019 [cited by applicant]
US 20200093435A1 · Masri et al. · 2020 [cited by applicant]
Lennon, “New test could cause OSA's treatment success rate to rise”, Chest Physician, MDedge New, Aug. 14, 2017, 4 pages http://www.mdedge.com/chestphysician/article/144587/pulmonology/new-test-could-cause-osas-treatmen… [cited by applicant]
Kastoer et al., “The Use of Remotely Controlled Mandibular Positioner as a Predictive Screening Tool for Mandibular Advancement Device Therapy in Patients with Obstructive Sleep Apnea through Single-Night Progressive Ti… [cited by applicant]
PCT/US/2020/060625, International Search Report and Written Opinion, Mar. 4, 2021 (13 pages). [cited by applicant]